Gallium ga 68 dotatate Alternatives Compared
| Gallium ga 68 dotatate | Neuraceq (florbetaben f-18) | Rubidium chloride rb-82 |
|
|---|
| Gallium ga 68 dotatate | Neuraceq (florbetaben f-18) | Rubidium chloride rb-82 |
|
|---|---|---|---|
|
Prescription only
Prescribed for Positron Emission Tomography Imaging. Gallium ga 68 dotatate may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Positron Emission Tomography Imaging. Neuraceq may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Positron Emission Tomography Imaging. Rubidium chloride rb-82 may also be used for purposes not listed in this medication guide. |
Related suggestions Positron Emission Tomography Imaging
|
| More about Gallium ga 68 dotatate | More about Neuraceq (florbetaben f-18) | More about Rubidium chloride rb-82 | |
| Ratings & Reviews | |||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||
|
View all Gallium ga 68 dotatate side effects |
View all Neuraceq side effects |
View all Rubidium chloride rb-82 side effects |
|
| Drug Class | |||
| Generic Availability | |||
|
N/A |
N/A |
||
| Pricing and Coupons * Prices are without insurance | |||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | |||
|
N/A |
N/A |
N/A |
|
| Brand Names | |||
| Netspot |
N/A |
Cardiogen-82, Ruby-Fill | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||
|
1.13 hours |
1 hour |
0.02 hours |
|
| CSA Schedule 1 View glossary of CSA terms | |||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | |||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
|
|
| Drug Interactions | |||
|
A total of 3 drugs are known to interact with Gallium ga 68 dotatate:
|
A total of 1 drugs are known to interact with Neuraceq:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Alcohol/Food/Lifestyle Interactions | |||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | |||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| First Approval Date | |||
|
N/A |
March 19, 2014 |
December 29, 1989 |
|
| WADA Class View classifications | |||
|
N/A |
N/A |
N/A |
|
| More Information | |||
| Patient Resources | |||
| Professional Resources | |||
|
N/A |
N/A |
||
| Related Treatment Guide | |||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.